What is the recommended dosage and treatment plan for Augmentin (amoxicillin-clavulanate) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin (Amoxicillin-Clavulanate) Dosing Recommendations

For adults with standard bacterial infections, use Augmentin 875 mg/125 mg twice daily for respiratory, skin, and soft tissue infections, or 500 mg/125 mg three times daily for mild-to-moderate infections, with treatment duration of 5-7 days for most infections and 10 days for streptococcal infections. 1, 2, 3

Standard Adult Dosing Regimens

Twice-Daily Dosing (Most Common)

  • 875 mg/125 mg twice daily is the preferred regimen for respiratory tract infections including acute bacterial rhinosinusitis, community-acquired pneumonia, and acute exacerbations of chronic bronchitis 1
  • This same dose applies to skin and soft tissue infections, urinary tract infections, and animal or human bites 1, 2
  • 500 mg/125 mg twice daily is appropriate for mild-to-moderate infections and specifically recommended for animal or human bites 1, 2

Three-Times-Daily Dosing

  • 500 mg/125 mg three times daily provides adequate coverage for mild-to-moderate infections when extended dosing is preferred 1
  • This regimen is specifically recommended for acute bacterial rhinosinusitis for 10 days 1
  • For recurrent streptococcal pharyngitis in adults with multiple episodes, use 500 mg twice daily for 10 days 1

Critical Warning: Never substitute two 250 mg tablets for one 500 mg tablet, as this results in excessive clavulanate dosing and increased gastrointestinal side effects 1

Pediatric Dosing (Age ≥3 Months and Weight <40 kg)

Standard Infections

  • Mild/Moderate infections: 25 mg/kg/day (amoxicillin component) divided every 12 hours OR 20 mg/kg/day divided every 8 hours 3
  • Severe infections or lower respiratory tract infections: 45 mg/kg/day divided every 12 hours OR 40 mg/kg/day divided every 8 hours 3

High-Dose Regimen for Resistant Pathogens

  • 90 mg/6.4 mg/kg/day (amoxicillin/clavulanate) in two divided doses for acute otitis media with risk factors for resistant organisms, particularly penicillin-resistant Streptococcus pneumoniae 2, 4, 5, 6
  • This high-dose formulation (Augmentin ES-600) provides a 14:1 ratio of amoxicillin to clavulanate, minimizing clavulanate-related diarrhea while maximizing efficacy against resistant pathogens 6

Infants <3 Months

  • Maximum dose is 30 mg/kg/day divided every 12 hours due to immature renal function 3
  • Minimum 10-day treatment for Streptococcus pyogenes to prevent acute rheumatic fever 3

Treatment Duration by Indication

Standard Durations

  • Skin and soft tissue infections: 5-7 days after clinical improvement 2
  • Animal or human bites: 5-7 days 2
  • Acute bacterial rhinosinusitis: 5-7 days in adults 1
  • Community-acquired pneumonia: 5-7 days if afebrile for 48 hours and clinically stable 2

Extended Durations

  • Any streptococcal infection: Minimum 10 days to prevent acute rheumatic fever 1, 3
  • Chronic streptococcal carriers: 10 days with 500 mg twice daily (adults) or 40 mg/kg/day in three divided doses (pediatrics) 1

Special Indications

  • Helicobacter pylori triple therapy: 1 gram amoxicillin + 500 mg clarithromycin + 30 mg lansoprazole, all twice daily for 14 days 3
  • H. pylori dual therapy: 1 gram amoxicillin + 30 mg lansoprazole, both three times daily for 14 days 3

Intravenous Dosing for Severe Infections

  • 1.2 g IV every 8 hours for serious infections including complicated intra-abdominal infections, severe respiratory infections, and severe skin/soft tissue infections 2, 7
  • For intra-abdominal infections with adequate source control, treat for 4-7 days 2
  • For moderate to severe community-acquired pneumonia requiring hospitalization, continue three-times-daily dosing 2
  • Consider increasing to every 6 hours (QID) for critically ill patients or severe sepsis 2

Renal Impairment Dosing

Patients with GFR <30 mL/min should NOT receive the 875 mg dose 3

Adjusted Regimens

  • GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours depending on infection severity 3
  • GFR <10 mL/min: 500 mg or 250 mg every 24 hours depending on infection severity 3
  • Hemodialysis: 500 mg or 250 mg every 24 hours, with an additional dose during and at the end of dialysis 3

Administration Considerations

  • Take at the start of a meal to minimize gastrointestinal intolerance 3
  • Continue treatment for minimum 48-72 hours beyond symptom resolution or evidence of bacterial eradication 3
  • Oral suspension must be shaken well before use and discarded after 14 days; refrigeration is preferable but not required 3

Clinical Decision Algorithm

  1. Identify infection type and severity

    • Mild-to-moderate: 500/125 mg formulation
    • Severe or respiratory: 875/125 mg formulation 1
  2. Assess patient factors

    • Renal function: Adjust dose if GFR <30 mL/min 3
    • Age: Use weight-based dosing for pediatrics <40 kg 3
    • Risk for resistant pathogens: Consider high-dose formulation (90/6.4 mg/kg/day) in children 5, 6
  3. Select dosing frequency

    • Twice daily for most standard infections 1, 2
    • Three times daily for rhinosinusitis or when extended coverage preferred 1
  4. Determine duration

    • 5-7 days for most infections 2
    • 10 days mandatory for streptococcal infections 1, 3

Common Pitfalls to Avoid

  • Do not use 875 mg dose in patients with severe renal impairment (GFR <30 mL/min) 3
  • Do not substitute tablet strengths to achieve desired amoxicillin dose, as this alters clavulanate exposure 1
  • Do not shorten treatment duration for streptococcal infections below 10 days, regardless of clinical improvement 1, 3
  • Gastrointestinal side effects occur in approximately 9% of patients and are generally less frequent with twice-daily versus three-times-daily dosing 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.